Embrace Molecule Complexity With Optimized Expression Technologies

Source: Lonza

Biologic drugs are increasingly complex, creating numerous challenges for biopharmaceutical companies, from higher candidate failure rates to expression and manufacturing obstacles. Lonza's Mammalian and Microbial expression systems and processes address the needs of more complex candidates, including vector design, cell line and strain selection and analytics to measure product quality attributes. In this webinar, case studies are discussed demonstrating the range of expression capabilities across mammalian and microbial derived molecules.

Who Should Watch This Webinar

Anyone active in:

  • Drug Substance Manufacturing
  • Drug Discovery
  • Executive Management, covering multiple areas
  • Outsourcing / Purchasing & Procurement
  • Preclinical Product Development
  • Process Development
  • Quality Assurance / Quality Control
  • Research & Development / R&D Management
  • Regulatory / Compliance
access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online